| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| FGF19 | Human FGF19 Protein, His Tag (BLI verified) | Human | E. coli | ![]() | SDS-PAGE | $360.00 100ug | ||
| FGF19 | Human FGF19 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $360.00 100ug | ||
| FGF19 | Human FGF19 Protein, Mouse IgG2a Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $360.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Aldafermin | M-70; NGM-282; M70; NGM282 | Phase 2 Clinical | NGM Biopharmaceuticals Inc | Bile acid malabsorption (BAM); Cholangitis, Sclerosing; Constipation; Diabetes Mellitus; Diarrhea; Fibrosis; Hepatic Insufficiency; Irritable Bowel Syndrome; Liver Cirrhosis, Biliary; Malabsorption Syndromes; Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency | Details |
| HH-009 | Phase 1 Clinical | Huahui Health Ltd | Neoplasms; Solid tumours | Details |
